FormDSignal
52

NextPoint Therapeutics, Inc. raises $33.7M under Reg D

Company raise · Raising · CAMBRIDGE, MA · Form D filed 2026-07-30
$10M+ raiseFirst raise on EDGAR

Why now — by persona

Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.

People on the filing

Paulina HillDirector
Ivan CheungExecutive Officer, Director
R. Jacob VogelsteinDirector
Jeffrey LaceyExecutive Officer
Brian ShusterDirector
Detlev BiniszkiewiczDirector
Rakhshita DharDirector
Axel HoosDirector

Signed by Jeffrey Lacey, Secretary & Treasurer.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.